These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31691527)

  • 41. INHBB promotes tumor aggressiveness and stemness of glioblastoma via activating EGFR signaling.
    Yang X; Jia Q; Zou Z; Liu X; Li X; Chen H; Ma H; Chen L
    Pathol Res Pract; 2023 May; 245():154460. PubMed ID: 37116368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined Inhibition of HDAC and EGFR Reduces Viability and Proliferation and Enhances STAT3 mRNA Expression in Glioblastoma Cells.
    Buendia Duque M; Pinheiro KV; Thomaz A; da Silva CA; Freire NH; Brunetto AT; Schwartsmann G; Jaeger M; de Farias CB; Roesler R
    J Mol Neurosci; 2019 May; 68(1):49-57. PubMed ID: 30887411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.
    Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M
    Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coactivator MYST1 regulates nuclear factor-κB and androgen receptor functions during proliferation of prostate cancer cells.
    Jaganathan A; Chaurasia P; Xiao GQ; Philizaire M; Lv X; Yao S; Burnstein KL; Liu DP; Levine AC; Mujtaba S
    Mol Endocrinol; 2014 Jun; 28(6):872-85. PubMed ID: 24702180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasion.
    Zheng Y; Yang W; Aldape K; He J; Lu Z
    J Biol Chem; 2013 Nov; 288(44):31488-95. PubMed ID: 24045955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.
    Yin D; Ogawa S; Kawamata N; Leiter A; Ham M; Li D; Doan NB; Said JW; Black KL; Phillip Koeffler H
    Oncogene; 2013 Feb; 32(9):1155-63. PubMed ID: 22580610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma.
    Katanasaka Y; Kodera Y; Kitamura Y; Morimoto T; Tamura T; Koizumi F
    Mol Cancer; 2013 Apr; 12():31. PubMed ID: 23617883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.
    Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B
    J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.
    Manzano S; Gutierrez-Uzquiza A; Bragado P; Sequera C; Herranz Ó; Rodrigo-Faus M; Jauregui P; Morgner S; Rubio I; Guerrero C; Porras A
    Cell Death Dis; 2021 Apr; 12(4):348. PubMed ID: 33824275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma specimens.
    Pedron S; Wolter GL; Chen JE; Laken SE; Sarkaria JN; Harley BAC
    Biomaterials; 2019 Oct; 219():119371. PubMed ID: 31352310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway.
    Sun J; Xu Y; Liu J; Cui H; Cao H; Ren J
    Cancer Sci; 2022 Feb; 113(2):500-516. PubMed ID: 34812552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma.
    Song Y; Jiang Y; Tao D; Wang Z; Wang R; Wang M; Han S
    Neuro Oncol; 2020 Jan; 22(1):46-57. PubMed ID: 31400279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3.
    Sang Y; Li Y; Song L; Alvarez AA; Zhang W; Lv D; Tang J; Liu F; Chang Z; Hatakeyama S; Hu B; Cheng SY; Feng H
    Cancer Res; 2018 Apr; 78(7):1792-1804. PubMed ID: 29386185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
    Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis.
    Zhu H; Acquaviva J; Ramachandran P; Boskovitz A; Woolfenden S; Pfannl R; Bronson RT; Chen JW; Weissleder R; Housman DE; Charest A
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2712-6. PubMed ID: 19196966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CEBPD is a master transcriptional factor for hypoxia regulated proteins in glioblastoma and augments hypoxia induced invasion through extracellular matrix-integrin mediated EGFR/PI3K pathway.
    Mao XG; Xue XY; Lv R; Ji A; Shi TY; Chen XY; Jiang XF; Zhang X
    Cell Death Dis; 2023 Apr; 14(4):269. PubMed ID: 37059730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of Tripartite Motif-Containing 48 (TRIM48) Inhibits Growth of Human Glioblastoma Cells by Suppressing Extracellular Signal Regulated Kinase 1/2 (ERK1/2) Pathway.
    Xue LP; Lu B; Gao BB; Shi YY; Xu JQ; Yang R; Xu B; Ding P
    Med Sci Monit; 2019 Nov; 25():8422-8429. PubMed ID: 31703057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glutamate promotes cell growth by EGFR signaling on U-87MG human glioblastoma cell line.
    Schunemann DP; Grivicich I; Regner A; Leal LF; de Araújo DR; Jotz GP; Fedrigo CA; Simon D; da Rocha AB
    Pathol Oncol Res; 2010 Jun; 16(2):285-93. PubMed ID: 19997873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TNF Inhibitor Pomalidomide Sensitizes Glioblastoma Cells to EGFR Inhibition.
    Luo Z; Wang B; Liu H; Shi L
    Ann Clin Lab Sci; 2020 Jul; 50(4):474-480. PubMed ID: 32826244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temozolomide induces the production of epidermal growth factor to regulate MDR1 expression in glioblastoma cells.
    Munoz JL; Rodriguez-Cruz V; Greco SJ; Nagula V; Scotto KW; Rameshwar P
    Mol Cancer Ther; 2014 Oct; 13(10):2399-411. PubMed ID: 25053824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.